Your Input: | |||||
SOCS5 | Suppressor of cytokine signaling 5. (536 aa) | ||||
NLRP3 | NLR family pyrin domain containing 3. (1036 aa) | ||||
IL23R | Interleukin 23 receptor. (629 aa) | ||||
IL18 | Interleukin-18; A proinflammatory cytokine primarily involved in polarized T- helper 1 (Th1) cell and natural killer (NK) cell immune responses. Upon binding to IL18R1 and IL18RAP, forms a signaling ternary complex which activates NF-kappa-B, triggering synthesis of inflammatory mediators. Synergizes with IL12/interleukin-12 to induce IFNG synthesis from T- helper 1 (Th1) cells and natural killer (NK) cells. Belongs to the IL-1 family. (193 aa) | ||||
FOXP3 | Forkhead box P3. (441 aa) | ||||
PRKCQ | Protein kinase C; Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PKC subfamily. (758 aa) | ||||
ANXA1 | Annexin. (346 aa) | ||||
CD81 | Tetraspanin. (270 aa) | ||||
CD3E | CD3e molecule. (207 aa) | ||||
HLX | H2.0 like homeobox. (493 aa) | ||||
MYB | MYB proto-oncogene, transcription factor. (768 aa) | ||||
TNFSF4 | TNF superfamily member 4; Belongs to the tumor necrosis factor family. (183 aa) | ||||
CCL19 | C-C motif chemokine. (98 aa) | ||||
SHB | SH2 domain-containing protein. (285 aa) | ||||
CD86 | CD86 molecule. (329 aa) | ||||
ENSPPAP00000021246 | SOCS box domain-containing protein. (478 aa) | ||||
NFKBIZ | NFKB inhibitor zeta. (706 aa) | ||||
CD28 | CD28 molecule. (220 aa) | ||||
CARD11 | Caspase recruitment domain family member 11. (1154 aa) | ||||
IL12RB1 | Interleukin 12 receptor subunit beta 1. (662 aa) | ||||
ZBTB7B | Zinc finger and BTB domain containing 7B. (573 aa) | ||||
SASH3 | SAM and SH3 domain containing 3. (380 aa) | ||||
IL12B | Interleukin-12 subunit beta; Cytokine that can act as a growth factor for activated T and NK cells, enhance the lytic activity of NK/lymphokine-activated killer cells, and stimulate the production of IFN-gamma by resting PBMC. (328 aa) | ||||
MALT1 | MALT1 paracaspase. (786 aa) | ||||
NCKAP1L | NCK associated protein 1 like. (1127 aa) | ||||
NFKBID | ANK_REP_REGION domain-containing protein. (465 aa) | ||||
CD80 | CD80 molecule. (288 aa) | ||||
IL2RG | Fibronectin type-III domain-containing protein. (369 aa) | ||||
LGALS9 | Galectin. (355 aa) | ||||
IL4R | Interleukin 4 receptor. (873 aa) | ||||
CD83 | CD83 molecule. (205 aa) | ||||
HLA-DRA | Major histocompatibility complex, class II, DR alpha; Belongs to the MHC class II family. (254 aa) | ||||
GIMAP1 | Uncharacterized protein. (500 aa) | ||||
IFNG | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. (166 aa) | ||||
PRKCZ | Protein kinase C; Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PKC subfamily. (522 aa) | ||||
IL23A | Interleukin 23 subunit alpha. (189 aa) | ||||
TGFBR2 | TGF-beta receptor type-2; Transmembrane serine/threonine kinase forming with the TGF- beta type I serine/threonine kinase receptor, TGFBR1, the non- promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinoge [...] (570 aa) | ||||
RARA | Uncharacterized protein. (609 aa) | ||||
RIPK2 | Receptor-interacting serine/threonine-protein kinase 2; Serine/threonine/tyrosine kinase that plays an essential role in modulation of innate and adaptive immune responses. Upon stimulation by bacterial peptidoglycans, NOD1 and NOD2 are activated, oligomerize and recruit RIPK2 through CARD-CARD domains. (551 aa) |